EGFR tyrosine kinase inhibitors plus bevacizumab for advanced non-small cell lung cancer with concurrent alterations: A retrospective study

Eurasian Journal of Medicine and Oncology · Published 2026-06-10 · DOI 10.36922/ejmo026060066

Free full text

Authors (11)

Ling Zhou, Xiaojun Yang, Xiumao Yin, Wan Zhang, Qinquan Tan, Yihong Zeng, Yanmin Cai, Haiji Yuan, Jia Chen, Weidong Liu, Guanming Jiang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhou, L., Yang, X., Yin, X., et al. (2026). EGFR tyrosine kinase inhibitors plus bevacizumab for advanced non-small cell lung cancer with concurrent alterations: A retrospective study. Eurasian Journal of Medicine and Oncology. https://doi.org/10.36922/ejmo026060066

Related articles